Giovanna Cenini

Giovanna Cenini

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GCGiovanna Cenini
Giovanna Cenini
Ana LloretAna Lloret
Ana Lloret
RCRoberta Cascella
Roberta Cascella
Age is the main risk factor for a number of human diseases, including neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, which increasing numbers of elderly individuals suffer. These pathological conditions are characterized by progressive loss of neuron cells, compromised motor or cognitive functions, and accumulation of abnormally aggregated proteins. Mitochondrial dysfunction is one of the main features of the aging process, particularly in organs requiring a high-energy source such as the heart, muscles, brain, or liver. Neurons rely almost exclusively on the mitochondria, which produce the energy required for most of the cellular processes, including synaptic plasticity and neurotransmitter synthesis. The brain is particularly vulnerable to oxidative stress and damage, because of its high oxygen consumption, low antioxidant defenses, and high content of polyunsaturated fats very prone to be oxidized. Thus, it is not surprising the importance of protecting systems, including antioxidant defenses, to maintain neuronal integrity and survival. Here, we review the role of mitochondrial oxidative stress in the aging process, with a specific focus on neurodegenerative diseases. Understanding the molecular mechanisms involving mitochondria and oxidative stress in the aging and neurodegeneration may help to identify new strategies for improving the health and extending lifespan.

23 August 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
GCGiovanna Cenini
Giovanna Cenini
WVWolfgang Voos
Wolfgang Voos
Alzheimer disease (AD) is a progressive and deleterious neurodegenerative disorder that affects mostly the elderly population. At the moment, no effective treatments are available in the market, making the whole situation a compelling challenge for societies worldwide. Recently, novel mechanisms have been proposed to explain the etiology of this disease leading to the new concept that AD is a multifactor pathology. Among others, the function of mitochondria has been considered as one of the intracellular processes severely compromised in AD since the early stages and likely represents a common feature of many neurodegenerative diseases. Many mitochondrial parameters decline already during the aging, reaching an extensive functional failure concomitant with the onset of neurodegenerative conditions, although the exact timeline of these events is still unclear. Thereby, it is not surprising that mitochondria have been already considered as therapeutic targets in neurodegenerative diseases including AD. Together with an overview of the role of mitochondrial dysfunction, this review examines the pros and cons of the tested therapeutic approaches targeting mitochondria in the context of AD. Since mitochondrial therapies in AD have shown different degrees of progress, it is imperative to perform a detailed analysis of the significance of mitochondrial deterioration in AD and of a pharmacological treatment at this level. This step would be very important for the field, as an effective drug treatment in AD is still missing and new therapeutic concepts are urgently needed.

24 June 2009 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
PDF file
MPMarzia Perluigi
Marzia Perluigi
RSRukhsana Sultana
Rukhsana Sultana
GCGiovanna Cenini
Giovanna Cenini
Fabio Di DomenicoFabio Di Domenico
Fabio Di Domenico
Maurizio MemoMaurizio Memo
Maurizio Memo
David Allan ButterfieldDavid Allan Butterfield
David Allan Butterfield

1 August 2013 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
Fabio Di DomenicoFabio Di Domenico
Fabio Di Domenico
RCRaffaella Coccia
Raffaella Coccia
ACAnnalisa Cocciolo
Annalisa Cocciolo
MMM. Paul Murphy
M. Paul Murphy
GCGiovanna Cenini
Giovanna Cenini
MPMarzia Perluigi
Marzia Perluigi

21 May 2008 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
GCGiovanna Cenini
Giovanna Cenini
RSRukhsana Sultana
Rukhsana Sultana
Maurizio MemoMaurizio Memo
Maurizio Memo
David Allan ButterfieldDavid Allan Butterfield
David Allan Butterfield
Oxidative stress has been implicated in the pathogenesis of Alzheimer's disease (AD). Both AD and arguably its earlier form, mild cognitive impairment (MCI), have elevated membrane oxidative damage in brain. The tumor suppressor and transcription factor p53 plays a pivotal function in neuronal apoptosis triggered by oxidative stress. Apoptosis contributes to neuronal death in many neurological disorders, including AD. In this study, we investigated p53 expression in a specific region of the cerebral cortex, namely the inferior parietal lobule (IPL), in MCI and AD brain, to test the hypothesis that alterations of this pro‐apoptotic protein may be involved in neuronal death in the progression of AD. By immunoprecipitation assay, we also investigated whether 4‐hydroxy‐2‐transnonenal (HNE), an aldehydic product of lipid peroxidation, was bound in excess to p53 in IPL from subjects with MCI and AD compared to control. Overall, the data provide evidence that p53 is involved in the neuronal death in both MCI and AD, suggesting that the observed alterations are early events in the progression of AD. In addition, HNE may be a novel non‐protein mediator of oxidative stress‐induced neuronal apoptosis.

1 February 2012 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
GCGiovanna Cenini
Giovanna Cenini
ADAmy L.S. Dowling
Amy L.S. Dowling
TBTina L. Beckett
Tina L. Beckett
Eugenio BaroneEugenio Barone
Eugenio Barone
CMCesare Mancuso
Cesare Mancuso
EHElizabeth Head
Elizabeth Head